P3 Health Partners Inc. Class A (PIII)

P3 Health Partners' stock experienced a significant decline of 72.00% between January 2, 2025, and December 31, 2025. Key events impacting the stock include missing Q3 2025 earnings estimates, facing a Nasdaq compliance challenge, and analyst price target reductions. The stock has been trading near its 52-week low, with daily fluctuations and further price target reductions in early January 2026.

P3 Health Partners experiences demand seasonality, anticipating a slightly softer fourth quarter due to colder months and the onset of cold and flu season. However, there is increased demand from payers and providers for value-based care.

P3 Health Partners, Inc. is a patient-centered and physician-led population health management company focused on transforming healthcare by improving the lives of patients and providers in the United States. The company operates in the Health Care sector and the Medical/Nursing Services industry, providing care services through clinics and wellness centers. Its offerings include data-driven solutions that support health plans in improving quality measures, risk adjustment accuracy, and operational efficiency. The company was founded in 2020 and is headquartered in Henderson, Nevada.

P3 Health Partners provides care services across the United States with a network of more than 2,800 affiliated primary care providers across 24 counties in multiple states. In December 2025, P3 Health Partners expanded its footprint through a joint venture with Commonwealth Primary Care ACO.

P3 Health Partners' brand reputation has likely been negatively impacted by its financial performance and operational challenges, including missing analyst earnings estimates in Q3 2025 and facing a Nasdaq compliance challenge in November 2025. The decline in stock price also reflects a challenging period for the company.

P3 Health Partners Inc. is primarily owned by institutional shareholders and insiders. Institutional shareholders hold 4.56% of the company's stock, with major holders including Alyeska Investment Group, L.P., and Vanguard Group Inc. Insiders hold a significant portion, accounting for 4,592.21% of the company's ownership, with Chicago Pacific Founders Ugp LLC being the largest individual shareholder. Retail investors hold 0.00% of the company's stock.